Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- PMID: 24379304
- PMCID: PMC3977608
- DOI: 10.1093/jac/dkt508
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
Abstract
The burden of human disease related to medically important fungal pathogens is substantial. An improved understanding of antifungal pharmacology and antifungal pharmacokinetics-pharmacodynamics has resulted in therapeutic drug monitoring (TDM) becoming a valuable adjunct to the routine administration of some antifungal agents. TDM may increase the probability of a successful outcome, prevent drug-related toxicity and potentially prevent the emergence of antifungal drug resistance. Much of the evidence that supports TDM is circumstantial. This document reviews the available literature and provides a series of recommendations for TDM of antifungal agents.
Keywords: fungal diseases; fungal pathogens; triazoles.
Similar articles
-
Antifungal therapeutic drug monitoring: focus on drugs without a clear recommendation.Clin Microbiol Infect. 2020 Nov;26(11):1481-1487. doi: 10.1016/j.cmi.2020.05.037. Epub 2020 Jun 11. Clin Microbiol Infect. 2020. PMID: 32535150 Review.
-
[Triazole antifungal agents: practice guidelines of therapeutic drug monitoring and perspectives in treatment optimization].Ann Biol Clin (Paris). 2014 Jul-Aug;72(4):391-404. doi: 10.1684/abc.2014.0968. Ann Biol Clin (Paris). 2014. PMID: 25119797 Review. French.
-
Therapeutic drug monitoring for triazoles.Curr Opin Infect Dis. 2008 Dec;21(6):580-6. doi: 10.1097/QCO.0b013e3283184611. Curr Opin Infect Dis. 2008. PMID: 18978525 Review.
-
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.Pharmacotherapy. 2023 Oct;43(10):1043-1050. doi: 10.1002/phar.2850. Epub 2023 Aug 14. Pharmacotherapy. 2023. PMID: 37459118 Review.
-
Therapeutic drug monitoring of azole antifungal agents.J Infect Chemother. 2025 Feb;31(2):102535. doi: 10.1016/j.jiac.2024.10.003. Epub 2024 Oct 5. J Infect Chemother. 2025. PMID: 39374735 Review.
Cited by
-
Scedosporium apiospermum and S. prolificans mixed disseminated infection in a lung transplant recipient: An unusual case of long-term survival with combined systemic and local antifungal therapy in intensive care unit.Med Mycol Case Rep. 2016 Apr 30;11:53-6. doi: 10.1016/j.mmcr.2016.04.006. eCollection 2016 Mar. Med Mycol Case Rep. 2016. PMID: 27222774 Free PMC article.
-
Histoplasmosis in Solid Organ Transplantation.J Fungi (Basel). 2024 Feb 2;10(2):124. doi: 10.3390/jof10020124. J Fungi (Basel). 2024. PMID: 38392796 Free PMC article. Review.
-
Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.Antimicrob Agents Chemother. 2015 Aug;59(8):4982-9. doi: 10.1128/AAC.00925-15. Epub 2015 Jun 8. Antimicrob Agents Chemother. 2015. PMID: 26055382 Free PMC article.
-
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.Antimicrob Agents Chemother. 2016 Aug 22;60(9):5595-9. doi: 10.1128/AAC.00389-16. Print 2016 Sep. Antimicrob Agents Chemother. 2016. PMID: 27324763 Free PMC article.
-
Dose Optimisation of Posaconazole and Therapeutic Drug Monitoring in Pediatric Patients.Front Pharmacol. 2022 Apr 19;13:833303. doi: 10.3389/fphar.2022.833303. eCollection 2022. Front Pharmacol. 2022. PMID: 35517786 Free PMC article.
References
-
- Bruggemann RJ, Donnelly JP, Aarnoutse RE, et al. Therapeutic drug monitoring of voriconazole. Ther Drug Monit. 2008;30:403–11. - PubMed
-
- Hope WW, Billaud EM, Lestner J, et al. Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis. 2008;21:580–6. - PubMed
-
- Lewis RE. Antifungal therapeutic drug monitoring. Curr Fungal Infect Rep. 2010;4:158–67.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical